RecruitingNCT07467837

Prevention of Stretch Marks in Expectant Mothers

Prevention (Reduction of Incidence) of Stretch Marks in Expectant Mothers

Sponsor

Stratpharma AG

Enrollment

10,000 participants

Start Date

Feb 24, 2026

Study Type

OBSERVATIONAL

Conditions

Pregnant women Stretch Mark

Summary

PRIME Mothers is a national observational trial designed to evaluate patient outcomes with Stratamark® for the prevention of stretch marks during pregnancy and the postpartum period. The study is designed to fit seamlessly into routine clinical practice, with digital follow-up and home resupply, minimising clinic involvement.

Eligibility

Sex: FEMALEMin Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Stratamark for people with pregnant women and stretch mark. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.